Clinical Trial: Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Brief Summary: The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution) 1.5% will have an effect on contact lens wear in patients with contact lens intolerance due to allergic conjunctivitis.
Detailed Summary:
Sponsor: Hom, Milton M., OD, FAAO
Current Primary Outcome: Questionnaire [ Time Frame: 8 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Hom, Milton M., OD, FAAO
Dates:
Date Received: April 14, 2011
Date Started: May 2011
Date Completion: November 2011
Last Updated: April 18, 2011
Last Verified: April 2011